SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-009513
Filing Date
2022-04-11
Accepted
2022-04-08 19:00:14
Documents
14
Period of Report
2022-04-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 46872
2 ex1-1.htm EX-1.1 237634
3 ex5-1.htm EX-5.1 13679
  Complete submission text file 0001493152-22-009513.txt   530002

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vynt-20220408.xsd EX-101.SCH 3033
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vynt-20220408_lab.xml EX-101.LAB 34476
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vynt-20220408_pre.xml EX-101.PRE 22595
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3705
Mailing Address 2370 STATE ROUTE 70 WEST SUITE 310 CHERRY HILL, NJ 08002
Business Address 2370 STATE ROUTE 70 WEST SUITE 310 CHERRY HILL, NJ 08002 201.528.9200
Vyant Bio, Inc. (Filer) CIK: 0001349929 (see all company filings)

IRS No.: 043462475 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35817 | Film No.: 22818215
SIC: 8071 Services-Medical Laboratories